v3.24.1.1.u2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 6,779 $ 11,523
Prepaid expenses 1,200 2,195
Grants revenue receivable 412 250
Other current assets 2,299 2,804
Total current assets 10,690 16,772
Operating lease right-of-use assets 8,647 9,161
Property and equipment, net 6,284 7,393
Other assets 1,498 2,057
Total assets 27,119 35,383
Current liabilities:    
Accounts payable 2,681 1,523
Accrued liabilities 2,748 4,279
Deferred revenue, current   9,031
Other current liabilities 3,152 2,488
Total current liabilities 8,581 17,321
Operating lease liabilities, long term portion 9,075 9,742
Contingent value right liability 2,158 2,702
Other liabilities 1,435 1,406
Total liabilities 21,249 31,171
Commitments and contingencies (Note 9)
Stockholders' equity    
Preferred stock, $0.001 par value per share: Authorized: 2,000,000 shares as of March 31, 2024 and December 31, 2023; Issued and outstanding: 250 shares as of March 31, 2024 and December 31, 2023
Common stock, $0.001 par value per share: Authorized: 150,000,000 shares as of March 31, 2024 and December 31, 2023; Issued and outstanding: 5,374,268 shares as of March 31, 2024 and December 31, 2023 5 5
Additional paid-in capital 458,185 457,099
Accumulated deficit (452,320) (452,892)
Total stockholders' equity 5,870 4,212
Total liabilities and stockholders' equity $ 27,119 $ 35,383

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL